Related Experiment Video
Updated: Nov 17, 2025
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
The E-Twenty-Six Family in Hepatocellular Carcinoma: Moving into the Spotlight
Tongyue Zhang1, Danfei Liu1, Yijun Wang1
1Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality worldwide. Although therapeutic strategies have recently advanced, tumor metastasis and drug resistance continue to pose challenges in the treatment of HCC. Therefore, new molecular targets are needed to develop novel therapeutic strategies for this cancer. E-twenty-six (ETS) transcription family has been implicated in human malignancies pathogenesis and progression, including leukemia, Ewing sarcoma, gastrointestinal stromal tumors. Recently, increasing studies have expanded its great potential as functional players in other cancers, including HCC. This review focuses primarily on the key functions and molecular mechanisms of ETS factors in HCC. Elucidating these molecular details may provide novel potential therapeutic strategies for cancers.
Insights
E-twenty-six (ETS) transcription factors are crucial in hepatocellular carcinoma (HCC) development. Understanding their roles offers new therapeutic targets for this challenging cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) presents significant global health challenges due to high morbidity and mortality.
- Current therapeutic advancements in HCC are hindered by tumor metastasis and drug resistance.
- Novel molecular targets are essential for developing effective HCC treatments.
Purpose of the Study:
- This review elucidates the critical functions and molecular mechanisms of E-twenty-six (ETS) transcription factors in HCC.
- It highlights the potential of ETS factors as therapeutic targets for HCC.
- The review aims to provide insights into novel treatment strategies for cancers.
Main Methods:
- Literature review focusing on ETS transcription factors in HCC.
- Analysis of published studies on the role of ETS factors in cancer pathogenesis and progression.
- Synthesis of information on molecular mechanisms and functional roles of ETS factors in HCC.
Main Results:
- ETS transcription factors are implicated in the pathogenesis and progression of various human malignancies.
- Emerging evidence demonstrates the significant potential of ETS factors in HCC.
- Specific molecular functions and mechanisms of ETS factors in HCC are detailed.
Conclusions:
- ETS transcription factors play key roles in HCC development and progression.
- Elucidating the molecular mechanisms of ETS factors can lead to novel therapeutic strategies for HCC.
- Targeting ETS factors may offer a promising avenue for future cancer therapies.
Related Concept Videos
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
01:21Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...